神経血管デバイス市場- 世界の産業規模、シェア、動向、機会、予測、デバイス別、治療用途別、エンドユーザー別、地域別、競合別、2020～2030年

神経血管デバイスの世界市場規模は2024年に74億8,000万米ドル、2030年には105億2,000万米ドルに達し、CAGR 5.82％で成長すると予測されています。

この市場は、脳卒中、動脈瘤、動静脈奇形などの神経血管疾患の有病率の増加によって急速に拡大しています。医療制度が早期介入を優先する中、迅速かつ低侵襲な治療を可能にする高度な神経血管技術へのニーズが高まっています。画像診断、カテーテルシステム、ステント回収法における技術の進歩は、患者の転帰と手技効率を著しく向上させています。低侵襲手技の利点に関するヘルスケア専門家や患者の意識の高まりも、より広範な採用に寄与しています。さらに、神経疾患にかかりやすい高齢者人口の増加が、早期回復を促し手術リスクを軽減する神経血管専門ソリューションへの需要をさらに押し上げています。

市場促進要因

脳卒中および神経血管障害の発生率の上昇

主な市場課題

デバイスと手技の高コスト

主要市場動向

人工知能（AI）と画像誘導ナビゲーションの採用増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の神経血管デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • デバイス別（脳塞栓術および動脈瘤コイル塞栓術デバイス、脳血管形成術およびステント留置システム、神経血栓除去デバイス、サポートデバイス、経橈骨動脈アクセスデバイス）
  • 治療用途別（脳卒中、脳動脈、脳動脈瘤、その他）
  • エンドユーザー別（病院、専門クリニック、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の神経血管デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の神経血管デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の神経血管デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の神経血管デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの神経血管デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Medtronic plc
• Stryker Corporation
• Terumo Corporation
• Penumbra, Inc.
• Johnson & Johnson Services, Inc.
• Integra LifeSciences Corporation
• Acandis GmbH
• Spiegelberg GmbH & Co. KG
• MicroPort Scientific Corporation
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Neurovascular Devices Market was valued at USD 7.48 Billion in 2024 and is projected to reach USD 10.52 Billion by 2030, growing at a CAGR of 5.82%. This market is expanding rapidly, fueled by the increasing prevalence of neurovascular conditions such as strokes, aneurysms, and arteriovenous malformations. As medical systems prioritize early intervention, there is a growing need for advanced neurovascular technologies that facilitate prompt and minimally invasive treatments. Technological progress in imaging, catheter systems, and stent retrieval methods has significantly enhanced patient outcomes and procedural efficiency. Rising awareness among healthcare professionals and patients regarding the benefits of minimally invasive procedures is also contributing to broader adoption. Additionally, the growing elderly population, which is more prone to neurological ailments, is further driving demand for specialized neurovascular solutions that promote faster recovery and reduce surgical risks.

Key Market Drivers

Rising Incidence of Stroke and Neurovascular Disorders

The increasing frequency of strokes and related neurovascular disorders is a major force behind the market's growth. Globally, strokes remain a leading cause of mortality and long-term disability, with over 12 million first-time stroke cases reported each year and around 6.5 million resulting in death, according to the World Stroke Organization. A significant proportion of these cases affect individuals under 70, and even a growing number under 50, underscoring the widespread nature of the issue. This surge in neurological conditions has accelerated the demand for prompt, minimally invasive interventions using advanced devices such as thrombectomy catheters, flow diverters, and embolization coils. These tools are essential for quickly restoring cerebral blood flow and reducing damage, ultimately leading to improved recovery outcomes. Furthermore, increased investment in specialized stroke centers and neurointervention capabilities is ensuring broader access to high-performance devices and timely care.

Key Market Challenges

High Cost of Devices and Procedures

The substantial cost associated with neurovascular devices and procedures remains a critical obstacle for the market. Products like stent retrievers, embolization coils, and flow diverters involve complex engineering and premium materials, which contribute to their elevated prices. For example, a Pipeline Embolization Device can cost upwards of USD 27,000, and the comprehensive cost of mechanical thrombectomy per patient often exceeds USD 285,000. These financial demands are compounded by the need for specialized imaging systems, trained professionals, and extended care, further inflating treatment expenses. Access is particularly constrained in low- and middle-income countries, while reimbursement inconsistencies in developed markets can also deter adoption. The financial burden on healthcare systems and patients continues to challenge the broader implementation of advanced neurovascular solutions.

Key Market Trends

Rising Adoption of Artificial Intelligence (AI) and Image-Guided Navigation

A prominent trend shaping the neurovascular devices market is the growing incorporation of Artificial Intelligence (AI) and image-guided navigation technologies. These innovations are enhancing diagnostic and procedural precision by enabling real-time visualization and data-driven decision-making. AI systems assist in the rapid interpretation of complex imaging data, improving detection and treatment planning for conditions such as aneurysms and strokes. Image-guided navigation facilitates safer and more effective placement of devices like stents and catheters by offering detailed vascular mapping. The integration of AI with high-resolution imaging technologies-such as MRI and CT angiography-not only supports personalized treatment strategies but also predicts outcomes and identifies risks before procedures begin. These advancements are streamlining workflows, reducing error rates, and promoting better clinical results, while continued investments in AI-driven platforms are expected to further accelerate innovation and adoption.

Key Market Players

• Medtronic plc
• Stryker Corporation
• Terumo Corporation
• Penumbra, Inc.
• Johnson & Johnson Services, Inc.
• Integra LifeSciences Corporation
• Acandis GmbH
• Spiegelberg GmbH & Co. KG
• MicroPort Scientific Corporation
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Report Scope

In this report, the Global Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurovascular Devices Market, By Device:

• Cerebral Embolization and Aneurysm Coiling Devices
• Cerebral Angioplasty and Stenting Systems
• Neurothrombectomy Devices
• Support Devices
• Trans Radial Access Devices

Neurovascular Devices Market, By Therapeutic Application:

• Stroke
• Cerebral Artery
• Cerebral Aneurysm
• Others

Neurovascular Devices Market, By End User:

• Hospitals
• Specialty Clinics
• Others

Neurovascular Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Devices Market.

Available Customizations

Global Neurovascular Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Neurovascular Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices)
  • 5.2.2. By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Neurovascular Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device
  • 6.2.2. By Therapeutic Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neurovascular Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device
      • 6.3.1.2.2. By Therapeutic Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Neurovascular Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device
      • 6.3.2.2.2. By Therapeutic Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Neurovascular Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device
      • 6.3.3.2.2. By Therapeutic Application
      • 6.3.3.2.3. By End User

7. Europe Neurovascular Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device
  • 7.2.2. By Therapeutic Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Neurovascular Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device
      • 7.3.1.2.2. By Therapeutic Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Neurovascular Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device
      • 7.3.2.2.2. By Therapeutic Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Neurovascular Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device
      • 7.3.3.2.2. By Therapeutic Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Neurovascular Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device
      • 7.3.4.2.2. By Therapeutic Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Neurovascular Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device
      • 7.3.5.2.2. By Therapeutic Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Neurovascular Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device
  • 8.2.2. By Therapeutic Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Neurovascular Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device
      • 8.3.1.2.2. By Therapeutic Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Neurovascular Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device
      • 8.3.2.2.2. By Therapeutic Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Neurovascular Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device
      • 8.3.3.2.2. By Therapeutic Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Neurovascular Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device
      • 8.3.4.2.2. By Therapeutic Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Neurovascular Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device
      • 8.3.5.2.2. By Therapeutic Application
      • 8.3.5.2.3. By End User

9. South America Neurovascular Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device
  • 9.2.2. By Therapeutic Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Neurovascular Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device
      • 9.3.1.2.2. By Therapeutic Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Neurovascular Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device
      • 9.3.2.2.2. By Therapeutic Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Neurovascular Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device
      • 9.3.3.2.2. By Therapeutic Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Neurovascular Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device
  • 10.2.2. By Therapeutic Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Neurovascular Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device
      • 10.3.1.2.2. By Therapeutic Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Neurovascular Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device
      • 10.3.2.2.2. By Therapeutic Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Neurovascular Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device
      • 10.3.3.2.2. By Therapeutic Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Stryker Corporation
• 15.3. Terumo Corporation
• 15.4. Penumbra, Inc.
• 15.5. Johnson & Johnson Services, Inc.
• 15.6. Integra LifeSciences Corporation
• 15.7. Acandis GmbH
• 15.8. Spiegelberg GmbH & Co. KG
• 15.9. MicroPort Scientific Corporation
• 15.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

16. Strategic Recommendations

17. About Us & Disclaimer